Ecolab delivered strong Q4 2024 performance with a 2% increase in revenue to $4.0 billion. Adjusted diluted EPS grew 17% to $1.81. Organic operating income margin improved by 150 bps to 17.4%. Segment performance was robust, with growth in Industrial and Institutional & Specialty segments offsetting a decline in Healthcare & Life Sciences. The company generated record free cash flow of $1.8 billion for the year.
Ecolab expects continued strong performance in 2025 with adjusted EPS projected in the range of $7.42 to $7.62, up 12% to 15%. Growth is expected to be driven by strong demand in key segments and improved value pricing.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance